La Salle D'exposition Fatboy Est Maintenant Ouverte Près De Royalmount : Elle Invite Les Clients À Faire L'expérience Du Plaisir, Du Confort Et Du Style !
05 sept. 2024 08h00 HE
|
Nuline distribution
MONTREAL, 05 sept. 2024 (GLOBE NEWSWIRE) -- Fatboy, la marque mondialement reconnue pour ses produits de style de vie innovateurs et ludiques, est heureuse d'annoncer l'ouverture de sa nouvelle...
Fatboy Showroom Now Open Near Royalmount: Inviting Customers to Experience Fun, Comfort, and Style!
05 sept. 2024 08h00 HE
|
Nuline distribution
Visit the Fatboy showroom near Royalmount for bold, fun, and innovative furniture and accessories. Discover comfort and style just minutes away!
Atari Reintroduces the Atari Club Jacket in Collaboration with 80s Fashion Icon Members Only®
14 nov. 2023 09h00 HE
|
Atari Inc.
Atari's collaboration with iconic fashion brand Members Only introduces an exclusive Atari Club jacket, specially discounted for Atari Club members.
Greencastle Media Group announces new strategic additions to its leadership team
01 févr. 2021 03h00 HE
|
Greencastle MM LLP
LONDON, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Greencastle Media Group (GMG), part of technology and media investment firm Greencastle Capital has today announced details of new strategic additions to...
Jounce Therapeutics Initiates Phase 2 EMERGE Study of Vopratelimab in Combination with Ipilimumab in Patients with Non-Small Cell Lung Cancer or Urothelial Cancer
18 juin 2019 08h00 HE
|
Jounce Therapeutics, Inc.
- Commenced patient enrollment in Phase 2 clinical trial of vopratelimab in combination with ipilimumab - - Preliminary efficacy and relationship to biomarker data expected in 2020 - CAMBRIDGE,...
Jounce Therapeutics Reports Second Quarter 2018 Financial Results
09 août 2018 06h30 HE
|
Jounce Therapeutics, Inc.
- Initiated enrollment in dose escalation cohorts of Phase 1/2 ICONIC trial of JTX-2011, in combination with ipilimumab and in combination with pembrolizumab - - Presented preliminary efficacy data...
Jounce Therapeutics Presents Preliminary Efficacy Data from Ongoing Phase 1/2 ICONIC Trial of JTX-2011 in Patients with Advanced Cancers
02 juin 2018 16h00 HE
|
Jounce Therapeutics, Inc.
CAMBRIDGE, Mass., June 02, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ:JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and...
Jounce Therapeutics to Present Data from Ongoing ICONIC Trial of JTX-2011 at the 2018 American Society of Clinical Oncology Annual Meeting
16 mai 2018 17h01 HE
|
Jounce Therapeutics, Inc.
ICONIC Target Enrollment Met Across Four Combination Cohorts Company to Host Investor Event and Live Webcast on Monday, June 4 CAMBRIDGE, Mass., May 16, 2018 (GLOBE NEWSWIRE) -- Jounce...
Jounce Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
08 mars 2018 06h30 HE
|
Jounce Therapeutics, Inc.
- Remain on track to announce preliminary efficacy data for the Phase 1/2 ICONIC trial in the second quarter of 2018 - - Reiterate 2018 strategy to advance clinical and research pipeline to drive...
SPRING 2016 FINE ART AUCTION SEASON AT MARTIN LAWRENCE GALLERIES
02 mars 2016 15h31 HE
|
Martin Lawrence Galleries
GREENWICH, Conn., March 2, 2016 (GLOBE NEWSWIRE) -- Martin Lawrence Galleries Spring 2016 art auction season is here. We open this month with a release of one thousand works by the biggest names in...